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Abstract
Purpose: Cell death is an essential process in normal development and homeostasis. In eyes, corneal epithelial injury leads
to the death of cells in underlying stroma, an event believed to initiate corneal wound healing. The molecular basis of
wound induced corneal stromal cell death is not understood in detail. Studies of others have indicated that ceramide may
play significant role in stromal cell death following LASIK surgery. We have undertaken the present study to investigate the
mechanism of death induced by C6 ceramide in cultures of human corneal stromal (HCSF) fibroblasts.
Methods: Cultures of HCSF were established from freshly excised corneas. Cell death was induced in low passage (p,4)
cultures of HCSF by treating the cells with C6 ceramide or C6 dihydroceramide as a control. Cell death was assessed by Live/
Dead cell staining with calcein AM and ethidium homodimer-1 as well as Annexin V staining, caspase activation and TUNEL
staining Mitochondrial dysfunction was assessed by Mito Sox Red, JC-1 and cytochrome C release Gene expression was
examined by qPCR and western blotting.
Results: Our data demonstrate ceramide caused mitochondrial dysfunction as evident from reduced MTT staining, cyto c
release from mitochondria, enhanced generation of ROS, and loss in mitochondrial membrane potential (DYm). Cell death
was evident from Live -Dead Cell staining and the inability to reestablish cultures from detached cells. Ceramide induced the
expression of the harikari gene(HRK) and up-regulated JNK phosphorylation. In ceramide treated cells HRK was translocated
to mitochondria, where it was found to interact with mitochondrial protein p32. The data also demonstrated HRK, p32 and
BAD interaction. Ceramide-induced expression of HRK, mitochondrial dysfunction and cell death were reduced by HRK
knockdown with HRK siRNA.
Conclusion: Our data document that ceramide is capable of inducing death of corneal stromal fibroblasts through the
induction of HRK mediated mitochondria dysfunction.
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Introduction
Mitochondria are the "power house" of the cell and as such
they are organelles that are critically involved in pathways of cell
death. In response to molecular cues from death stimuli,
mitochondria release molecules known as apoptosis inducing
factors, cytochrome c (cyto c) and generate reactive oxygen
species (ROS) in resulting cell death [1,2]. The mitochondrial
outer membrane permeabilization (MOMP) is a critical factor in
mitochondrial mediated cell death. In this process proteins
sequestered in the outer and inner mitochondrial membranes are
permitted to interact with the proteins of cytosol resulting in
conformational changes thus leading to demise of the cell [3].
MOMP is regulated by several classes of proteins that include
non Bcl2 members, Bcl-2 family members, and a subset of BH3
only proteins that share BCl-2 homology domain3 [4,5,6]. It has
been proposed that BH3-only proteins influence the MOMP
through directly binding and inactivating their specific anti-death
Bcl2 partners. On the other hand according to a "hierarchy
model" certain BH3-only proteins may bypass the direct binding
to pro or anti death proteins by acting upstream or downstream
of anti-death factors [6,7,8]. Thus, BH3 only proteins can cause
the mitochondrial dysfunction either dependent or independent
of pro-death factors BAX and BAK [6,8]. BH3-only protein
activities can be regulated by several ways in initiating the
different signals that ultimately converge on the mitochondria
causing its dysfunction and thereby the cell death [9]. Ceramide
has been associated with the regulation of Bcl-2 family as well as
BH3 only proteins [10].
Ceramide, the structural backbone of sphingolipids/sphingo-
myelin, is an important second messenger involved in cell growth,
differentiation, and death [11]. The specific mechanism(s) by
which ceramide regulates BH3-only protein activities relating to
mitochondrial dysfunction and cell death is not understood in
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on the mitochondrial integrity and functions including: genera-
tion of reactive oxygen species, ATP depletion, collapse in the
inner mitochondrial membrane potential, inhibition and/or
activation of the activities of various components of the
mitochondrial electron transport chain and release of inter-
membrane space (IMS) proteins [11,12]. Mitochondrial dysfunc-
tion has been implicated in the death of corneal fibroblasts and
corneal epithelial cells as evident by the release of cyto c, loss in
mitochondrial membrane potential (DYm), and ROS release
[13,14].
Corneal epithelial injury, as a result of keratorefractive
surgeries such as LASIK; lead to stromal cell death is a critical
event in corneal wound healing [15]. Ceramide has been
hypothesized to been involved in the response of stromal cells
to injury [16]. Ceramide can cause the death of rabbit corneal
stromal fibroblast grown in culture but the mechanism of cell
death was not determined [16]. BH3-only proteins such as BAD
and HRK are known to be regulated by ceramide in causing
death of non-ocular cell types. Ceramide induced dephosphor-
ylation of BAD in HepG2 [12] and Cos7 cells [17]. It also
induced the expression of HRK in oligodendrocytes [18].
Dephosphorylated BAD translocate to mitochondria, bypassing
BAX and BAK switch [12], whereas HRK directly interacted
with the mitochondrial protein p32, a protein known for its role
in causing mitochondrial dysfunction and cell death [19,20].
Thus, both BAD and HRK are capable of causing mitochondrial
dysfunction by directly acting with mitochondrial proteins,
independent of BAX and BAK.
The studies presented here investigate the molecular basis of
corneal stromal cell death induced by C6 ceramide. We
examined mitochondrial dysfunction and determined the role of
BH3 only protein, HRK, in mediating death. The key findings of
the present study are that C6 ceramide cause the release of cyto c
from mitochondria, generation of ROS, and collapse of DYm
documenting mitochondrial dysfunction. Ceramide caused rapid
transient JNK phosphorylation leading to enhanced expression of
HRK. HRK was translocated to mitochondria of ceramide treated
cells where it interacted with BAD and mitochondrial p32. These
observations suggest that BAD and HRK as BH3 only proteins
are directly involved in causing mitochondrial dysfunction
[12,19].
Materials and Methods
Cell culture
Human corneal stromal cells were isolated and grown as
fibroblasts (HCSF) from human donor eyes purchased from
Wisconsin’s Lion Eye Bank as previously described [21]. Briefly,
after removal of the corneal epithelium and endothelium the
stroma was digested for 16 h at 37uC with collagenase (Clostrid-
ium histolyticium, Invitrogen, Carlsbad, CA) in Hank’s balanced
salts solution (HBSS) containing penicillin G and streptomycin
sulfate (both from Sigma Aldrich, St. Louis, MO). Cells were
recovered by centrifugation, suspended in growth medium, and
grown at 34uC in Dulbecco’s Modified Eagle Medium (DMEM)
(Invitrogen),supplemented with 5% heat-inactivated defined fetal
bovine serum (FBS; Hyclone/ Thermo Scientific, Waltham, MA),
0.1% Mito+serum extender (BD Biosciences, San Jose, CA), and
10 mg/ml ciprofloxacin (Sigma Aldrich). Cells of the first four
passages were used for these studies. In the experiments where
fluorescent microscopy or fluorometry was performed cells were
incubated in DMEM without phenol red (31053, Invitrogen) while
other components remained the same.
Reagents
C6 ceramide (ceramide) and C6 dihydroceramide (dihydrocer-
amide); (BIOMOL International, Plymouth Meeting, PA) were
dissolved in DMSO (Sigma Aldrich, St Louis, MO) and used at
concentration of 0- 40 mM, SP600125 (Sigma Aldrich, St. Louis,
MO) was used at concentration of 10 mM. Antibodies included;
anti-HRK (AHP1178, AbD Serotec, Oxford, UK), anti-Cyto-
chrome c (SC-8385), anti-P32/C1QBP(SC-10258), anti-BAD(SC-
81442 Santa Cruz Biotechnology, Santa Cruz, CA); anti JNK-p/
SAPK-p ( 9251) and anti-JNK/SAPK(9252); Cell Signaling,
Danver, MA), b-actin (A5316), b-tubulin (T5201), SigmaAldrich,
St. Louis, MO). HRK ON-Target Plus siRNA pool (siHRK) and
non target control (siNTC) were purchased from Dharmacon
(Lafayette, CO). We determine the optimum concentration of
siRNA to be 40 nM concentration.
Live and Dead Cell Assay
HCSF were incubated for up to16 h in the presence or absence
of ceramide. Preliminary dose response assays confirmed that
40 mM ceramide was the ED50 for HCSF death. Cells were
treated for 1 h in the dark with 4 mM calcein-AM and 2 mM
ethidium homodimer-I (Eth-D1) prepared in 1XHBSS with Ca
and Mg. Live/dead cell measurement was done according to the
manufactures instructions (LIVE/DEAD Viability and Cytotox-
icity Kit) (Molecular Probes, Invitrogen).
MTT Assay
HCSF were plated at a density of about 1610
5 cells per cm
2 in
DMEM containing 5% FBS, Mito+ and ciprofloxacin. After 24 to
48 hrs the media was changed to DMEM containing 5 % FBS
without phenol red supplemented with 40 mM ceramide or
dihydroceramide. Growth and survival of HCSF was measured
based on the reduction of MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide. Briefly, 900 ml serum free medium
and 100 ml MTT solution (5 mg/ml in Ca2+ and Mg2+ free PBS,
(SigmaAldrich, St. Louis, MO) were added to each, well
containing cells and incubated at 34uC for 1 h-2 h. The insoluble
formazan was extracted with 1.0 ml isopropanol solution (con-
taining 0.04 M HCL; Fisher Scientific, USA), 1 ml per well, at
34uC for additional 15 min. The extracting liquid and cells were
harvested and centrifuged at 5,0006G for 10 min. The amount of
formazan in the supernatant was estimated by reading the
absorbance at 650 and 570. Three replicates were read for each
sample, the mean value was used as the final result.
Assessment of the Mitochondrial Membrane Potential
Changes in the mitochondrial membrane potential (DYm) were
measured using JC-1 dye (JC100, Cell Technology, Mountain
View, CA). Briefly, HCSF were seeded in at 70-80% confluent
levels and treated with 40 mM C6 ceramide or C6 dihydrocer-
amide in triplicates for 16 h. Cells along with floaters were pooled,
centrifuged ( 500 xg /5 min), washed with HBSS, resuspended
with JC-1 (1:200) in Hanks buffer with Ca
2+ and Mg
2+, and were
incubated (37uC; 30 minutes). Cells were then centrifuged
(500 xg/5 min) and washed at least three times with HBSS to
remove the excess probe. 100 ml of resuspended cell sample was
used to read the fluorescence in 96 wells assay clear bottom, black
plate (Costar 3603, Corning NY, USA) at Ex 498/ Em 535 and Ex
560/ Em590 in FLX800 micro plate fluorescent reader (Bio-Tek
Instrument). The ratio of red: green was calculated as Dym. For
fluorescent microscopy cells were also counterstained with 5 ml/
10 ml Hoechst 33342 (H3570, Invitrogen, Madison, WI) in HBSS
containing Ca
2+ and Mg
2+ and the images were captured.
Ceramide Induced Cell Death
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18137Mitochondrial Reactive Oxygen Species (ROS)
The intensity of mitochondrial ROS was analyzed by fluorescent
microscopy. C6 ceramide or C6 dihydroceramide treated HCSF
(48 h post-plating)grown in6 wellsplatesbriefly washed with HBSS
containing Ca
2+ and Mg
2+ and then incubated with DMSO soluble
5 mM MitoSOX
TM Red Superoxide Indicator(M36008, Invitro-
gen, Madison, WI) for 10 min at 34uC, protected from light. The
cells were washed, counterstained with 5 ml/10 ml Hoechst
33342(Invitrogen) in HBSS for another 10 minutes and used for
imaging.
Mitochondrial Isolation
Mitochondria from HCSF were isolated using Pierce mito-
chondrial isolation kit (89874, Pierce/Thermo, Rockford, IL) as
per option ‘A’ of the kit guidelines. Briefly, 2610
7HCSF grown in
T150 flask were pre-incubated for 3 h, 6 h and 12 h with C6
ceramide or C6 dihydroceramide. Floaters along with attached
cells were pooled and centrifuged together (10006g/5 minutes).
Cytosolic fraction was collected separately while mitochondrial
pellet was resuspended in RIPA buffer (sc 24948, Santa Cruz
Biotechnology, Santa Cruz, CA) mixed with Na3VO4, proteinase
inhibitor cocktail, and PMSF. Protein concentrations were
determined with the BCA Protein Assay Reagent Kit (Pierce/
Thermo Scientific, Rockford, IL). Both cytosolic and mitochon-
drial fractions were stored at 280uC till their use for Western.
Immunoblot Analysis
Media was removed and cells were lysed in modified RIPA lysis
buffer(Santa Cruz Biotech) supplemented with PMSF, Na3VO4,
and 1:10 protease inhibitor cocktail in 1X PBS made from tablets
(14654600, Roche Diagnostics, Indianapolis, IN). Lysates were
prepared by freeze thawing, Dounce homogenization, and
sonicated twice (15-s intervals at 100 W power). Cell debris was
cleared from the lysates (centrifuged 2006 g for 15 centrifuged
min at 4uC) and protein concentrations were determined with the
BCA Protein Assay Reagent Kit (Pierce/Thermo Scientific,
Rockford, IL). The lysates were stored at -80uC till their use.
For Western blotting 15 mgt o3 0mg proteins were loaded in each
lane of Tris HCl Criterion
TM 10% or 18%Tris-HCl polyacryl-
amide gels(BIO-RAD, Hercules, CA). SDS-PAGE was run and
proteins were electrophoretically transferred to PVDF filters.
Filters were blocked with 5% serum or non fat milk (1 h) followed
by overnight incubation at 4uC with primary antibodies in suitable
dilutions. Proteins were detected using the corresponding
horseradish peroxidase-conjugated antibody and Amersham
ECL western blotting reagent (RPN 2209, GE Healthcare, Little
Chalfont; UK), according to the manufacturer’s directions.
Development of the blots was done with Amersham Hyperfilm
ECL
TM high performance CL Film (GE Healthcare, Little
Chalfont; UK), using Kodak GBX developer and fixer solutions
(Pierce/Thermo Scientific, Rockford, IL). Blots were re-probed
after removing the antibodies and substrates with the Restore
Western Blot Stripping Buffer (Pierce/Thermo, Rockford, IL),
according to the manufacturer’s directions. Protein loading was
normalized by b-actin or b-tubulin signal,
Co-IP Studies
Samples prepared from C6 ceramide or C6 dihydroceramide
treated cells were lysed in IP lysis buffer. Pre-cleared lysates were
subjected to IP for overnight at 4uC with 0.002 mg/ml anti-p32 or
anti-BAD and additional 2 centrifuged hrs incubation at room
temp with agarose G beads (20398, Pierce/Thermo, Rockford,
IL). The IP mixtures were centrifuged at 80006g for 5 minutes
and the pellet was washed four times with (1X) washing buffer
(23225, Pierce/Thermo, Rockford, IL). The complex was
resuspended in RIPA buffer, and proteins were eluted with SDS
buffer for Western analysis to detect protein interactions among
BAD, HRK and P32.
Small interfering RNA treatment of cells
SiRNA complexes were formed in serum-free medium, using
INTERFERIN (PolyPlus; Genesee Scientific, San Diego, CA),
according to the manufacturer’s instructions. Optimal siRNA/
INTERFERIN concentrations were established. Cells were plated
at 45–50% confluence in DMEM containing 5% FBS, Mito+-
serum extender (Gibco, Carlsbad, CA), and ciprofloxacin and
maintained at 34uC. 24 h post-plating, the media was removed
and the cells rinsed with HBSS. The cells were treated with a final
concentration of 40 nM siRNA. Cells were transfected with
siRNA complexes in media composed of (1:50) INTERFERIN:
DMEM containing 5% FBS Mito+ and ciprofloxacin. After
overnight incubation (16 h), the transfection media was replaced
with regular culture media. 72 h post-transfection, cells were
treated with 40 mg C6 ceramide or C6 dihydroceramide (6–16 h
incubations) for relevant experiments.
RNA isolation, cDNA synthesis, Real-time (q) PCR
Total RNA was prepared from cells using Trizol (Invitrogen) and
was followed by DNA digestion with DNase I (Invitrogen, Madison,
WI) and further purified by RNeasy minikit protocol (Qiagen,
Valencia, CA). RNA concentrations were determined by measuring
the optical density at 260, 280 and 320 nm. Equal amounts of RNA
from each sample were then reverse transcribedto cDNA byusing a
Superscript first-strand synthesis kit (Invitrogen). qPCR were
performed in an ABI 7500 (Applied Biosystems), using SYBR
Green PCR Master Mix (Applied Biosystems) and 50–75 ng cDNA
at 50uC for 2 min, 95uC for 10 min, 40 cycles of 95uC for 15 s,
annealing for 1 min at 60uC, then extension at 72 uC for 45s. HRK
specific primers (PPH00369A, SA Biosciences, Frederick, MD) and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (S) 59-
ctctctgctcctcctgttcg-39, (AS) 59-tgactccgaccttcaccttc-39 primers were used in
the concentrations of 10 pM/20 ml. Melt curve analysis was
performed by an additional dissociation step of 1 cycle at 95uC
for15 sand rampingdatacollectionat60uCfor1 minand95uCfor
15 s. Ct values were calculated using ABI software. Data were
normalized against the GAPDH signal. Relative expression values
were obtained by normalizing Ct values of the tested genes with Ct
values of the housekeeping genes, using the DDCt method.
Statistical Analysis
Means were compared by t test or one-way analysis of variance,
and the significance of differences among means of treatment
groups was determined using Sigma Stat software (Sigma Stat 3.0;
SPSS Inc., Chicago, IL).
Results
Ceramide Caused HCSF Death
We observed that exogenous treatment with short chain
ceramides (C-2 or C-6) caused dose dependent (0 to 80 mM)
death of HCSF in manner similar to that observed with other cell
types [22]. For example, C6 ceramide significantly reduced the cell
viability compared to dihydroceramide or no treatment within
16 hours of exposure to HCSF (Figure 1). In the studies reported
here cell viability was quantified using calcein AM/EthD-1 double
staining (Figure 1A). Using the MTT assay, an indicator of
mitochondrial activity, we confirmed that ceramide treatment of
Ceramide Induced Cell Death
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e18137Figure 1. Ceramide induced cell death. A: HCSF were grown to confluence in DMEM (without phenol red) containing 5%FBS, Mito+, and
ciprofloxacin. The cells were treated with (a) 40 mM C6 dihydroceramide or (b) 40 mM C6 ceramide for 16 hrs, and then briefly washed with HBSS
containing Ca
2+ and Mg
2+ and incubated with calcein AM and ethidium nuclear stain (Invitrogen) for 30 min at 37uC. Cell death was determined by
fluorescent microscopy. Cell counts of dead cells were expressed as percentage of total cells counted. (c) The percent of calcein AM positive cells
(Mean6SEM) was significantly reduced in the C6 ceramide treated culture relative to C6 dihydroceramide treated controls (Mean6SEM)
(P=0.008 Mann-Whitney Rank Sum test). B: Assessment of cell death was also determined by MTT assay following treatment with C6 ceramide. HCSF
were grown to confluence in DMEM (without phenol red) containing 5% FBS, Mito+, and ciprofloxacin. The cells were treated for 16 hrs with (1)
40 mM C6 dihydroceramide, (2) 20 mM C6 ceramide or (3) 40 mM C6 ceramide. Ceramide induced cell death was measured by formazan formation.
MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium bromide, a tetrazole) was reduced to formazan by living cells. C6 ceramide treatment
decreased the formazan formation (Mean6SEM) compared to C6 dihydroceramide treated controls (Mean6SEM). (*)Statistically significant (p,0.001)
as determined by ANOVA with multiple comparisons (Holm-Sidak method).
doi:10.1371/journal.pone.0018137.g001
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of cell viability (Figure 1B) [23,24].
Ceramide Induced HCSF Death and Mitochondrial
Dysfunction
Release of cyto c from the mitochondria into the cytosol has been
observed to be among the ceramide regulated mitochondrial
propertiesthatinfluencecellsurvival[25,26,27].Ourdatadocument
cyto c immunoreactivity in the cytosolic fraction prepared from C6
ceramide treatedHCSFundergoingcelldeath.Incontrastcytoc was
confined to mitochondria in C6 dihydroceramide treated control
cells (Figure 2A). To evaluate mitochondrial ROS production and
membrane potential we employed MitoSOX Red and JC-1
fluorescent probes, respectively. Ourdata revealed that C6ceramide
exposure significantly enhanced mitochondrial ROS production as
evident from the increased intensity of red fluorescence in C6
ceramide treated HCSF (Figure 2B). Furthermore we observed a fall
Figure 2. Ceramide treatment caused HCSF mitochondrial dysfunction. A: C6 ceramide induced cytochrome c (cyto c) release from
mitochondria to cytoplasm was determined by Western blotting. HCSF grown in DMEM containing 5%FBS, Mito+, and ciprofloxacin were treated
with 40 mM C6 dihydroceramide or C6 ceramide for 16 hrs. Western blot of cell extracts from mitochondrial and cytosol fraction using antibodies to
cyto c showed release of cyto c from mitochondria. Vertical bars represent ratio of cyto c to b-actin (arbitrary values of relative quantification
normalized to loading control b-actin) (1) C6 dihydroceramide treated or (2) C6 ceramide treated mitochondrial fractions; (3) C6 dihydroceramide
treated or (4) C6 ceramide treated cytosol fractions. B: Mitochondrial membrane potential (Dym) changes were determined by fluorescence
microscopy. In cells treated with JC-1 the mitochondria of healthy cells fluoresce red while cells undergoing death fluoresce green when the
mitochondrial potential collapses. (b) C6 ceramide treated cultures stained with JC-1 show less intense J aggregate compared to C6 dihydroceramide
treated control (a); (d) green fluorescence indicating Dym loss compared to healthy mitochondria(c); (e) merged images (a and c), (f) merged images
(b and d). C: Mitochondrial membrane potential (Dym) red/green ratios were measured by fluorescence emission of red and green fluorescence using
a fluorescence plate reader. (NT) No treatment, (DH) C6 dihydroceramide control, (Cer) C6 ceramide treated cultures. C6 ceramide treatment
decreased the red green ratio (Mean6SEM) compared to controls (Mean6SEM) indicating Dym loss. (*) Statistically significantly different from no
treatment or DH treated groups. (p,0.05) ANOVA with multiple comparisons (Holm-Sidak method) was performed. D: Mitochondrial reactive oxygen
species (ROS) was analyzed by fluorescence microscopy. Cells grown in DMEM containing 5% FBS (without phenol red) were treated with C6
ceramide or C6 dihydroceramide for 16 hours. Cells were washed with HBSS containing Ca
2+ and Mg
2+ and incubated with MitoSOX Red for 10 min
at 37uC, protected from light. The cells were washed and counterstained with Hoechst 33342. MitoSOX Red-emitted fluorescence intensified in C6
ceramide treated cultures indicating an increased in ROS levels. (a) C6 dihydroceramide treated cells, (b) C6 ceramide treated cells.
doi:10.1371/journal.pone.0018137.g002
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and exposed to JC-1 (Figure 2C, 2D). The mitochondrial Dym
clearly decreased in C6 ceramide treated HCSF compared to C6
dihydroceramide treated counterparts. Thus ceramide treated
HCSF released cyto c into the cytosol, increased the production of
ROS and possessed a compromised the Dym. All of these alterations
in mitochondrial functions are believed to contribute to cell death
[2,10].
Ceramide Induced HRK Expression linked to
Mitochondrial Dysfunction and Cell Death
Preliminary studies using PCR arrays to assess the expression of
genes related to apoptosis following the first 6 to 12 hr post
ceramide treatment of HCSF indicated that the HRK gene was
significantly up regulated (data not shown). Using HRK specific
primers for qPCR and HRK specific antibodies for western
analysis we confirmed the preliminary observation made using the
arrays. HRK gene expression peaked in ceramide treated cells 6 h
post C6 ceramide treatment compared to C6 dihydroceramide or
no treatment control (Figure 3A). Western analysis documented
increased in HRK protein between 6 to 12 hours post-C6
ceramide treatment. HRK protein became associated with
mitochondria in samples from C6 ceramide treated HCSF in
12 hours (3B). HRK (Harakiri) belongs to the BH3 only protein
family originally identified in rat sympathetic neurons [28] and in
HeLA cells [29]. HRK expression has been demonstrated to play a
Figure 3. Interaction of HRK with Bad and p32. A: CeramideinducedHRKexpression.HCSFweregrowntoconfluenceinDMEMcontaining5%FBS,
Mito+, and ciprofloxacin. The cells were treated with 40 mM C6 ceramide for 3, 6 or 12 hours and compared with 40 mM C6 dihydroceramide as control
group. Real time (q) PCR usingHrk specific primers documented increased steady state pools of HRK mRNA at 6 hrs by C6 ceramide treatment compared to
C6 dihydroceramide. Vertical bars represent fold change (Mean 6 SEM) by C6 ceramide treatments with respect to dihydroceramide treatments at (1)
3 hours, (2) 6 hours and (3) 12 hours. B: Ceramide induced HRK translocation to mitochondria. HCSF grown in DMEM containing 5%FBS, Mito+,a n d
ciprofloxacin were treated with 40 mM C6 ceramide for 3, 6 and 12 hours. (a)Western blot of cell extracts from mitochondrial and cytosol fraction using
antibodies to HRK was performed. Vertical solid and hollow bars respectively represent ratio of HRK to b-actin in cytoplasm and mitochondria. (1) C6
dihydroceramidetreatedcontrolculturesorC6ceramidetreatedcultures(2)3 hrs,(3)6 hrs(4)12 hrs.C:Proteininteractionamongmitochondrialp32,HRK
and BAD. Cell lysates were prepared from 40 mM C6 ceramide and C6 dihydroceramide treated HCSF and Co-immunoprecipitations were performed. The
lysate was pre-cleared by G agarose and subjected to IP for overnight at 4uC with either anti-BAD or anti-p32 antibodies. HRK interaction with p32 and
Immunoblot (WB) withanti-HRK), HRK interactionwith BAD (IP with BAD; WB with anti-HRK), and p32 interaction withBAD (IPwithBAD; WB with anti-p32)
was determined by Western analysis. Non-immune host serum source of anti-p32 and anti BAD was used as mock control.
doi:10.1371/journal.pone.0018137.g003
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conditions [19,30]. HRK has been detected in tissues including
but not limited to brain, lymphoid tissues, pancreas, liver, lung,
and kidney [31]. This is the first report if its detection in tissues of
the eye. In oligodendrocytes it appeared that HRK was associated
with death by apoptosis [18]. Based on this information, we
envisaged ceramide induced HRK expression in HCSF could be
involved in cell death mediated by mitochondrial dysfunction but
as described below the process of ceramide induced cell death of
HCSF appeared to be more complicated that a pure apoptotic
process.
HRK-P32-BAD Interactions are Involved in Ceramide
Induced Mitochondria Dysfunction
Western blotting showed the HRK protein was primarily
localized in mitochondria (Figure 3B). Yeast two hybrid studies
have shown the existence of HRK interaction with mitochondrial
p32 [19] in the cells undergoing apoptosis. We confirmed this
association with mitochondrial p32 by applying co-immunopre-
cipitation. When p32 was immunoprecipitated, HRK was clearly
associated with the p32 precipitated (Figure 3C). Furthermore, we
demonstrated that just like HRK, co-immunoprecipitation of BAD
with p32 revealed that in HCSF, BAD too was associated with p32
(Figure 3C) under the influence of ceramide [12]. Thus in
ceramide treated HCSF interactions among HRK, p32 and BAD
in the mitochondria were likely contributor to cell death
(Figure 3C).
Ceramide Caused JNK Phosphorylation is Involved in HRK
Expression
Ceramide has been shown to activate stress-related kinases,
including stress-activated protein kinases (SAPKs) [32] and c-jun
NH2 terminal kinase (JNK) [33]. Western blots using anti JNK-p
to probe lysates prepared from C6 ceramide or C6 dihydrocer-
amide treated HCSF demonstrated increased JNK phosphoryla-
tion in the HCSF samples prepared 0.25 to 0.50 h post-ceramide
treatment relative to C6 dihydroceramide treated samples
(Figure 4A). JNK has been implicated in HRK expression [30].
In our studies C6 ceramide induced HRK expression was
significantly ablated by more than 75 percent in 6 hour and
about 30 percent in 12 hours when the JNK inhibitor, SP600125,
was added to the cell culture media (Figure 4B).
Figure 4. Ceramide induced JNK phosphorylation regulates HRK expression. A: HCSF grown in DMEM containing 5%FBS, Mito+, and
ciprofloxacin were treated with 40 mM C6 dihydroceramide as control or 40 mM C6 ceramide at various times. Western blot of cell lysates using
antibodies to (a) phospho-JNK (JNK-p), (b) JNK and (c) b actin demonstrated peak phosphorylation of JNK 30 to 60 minutes post-treatment. B: Vertical
bars represented as percent phosphorylation caused by ceramide with respect to C6 dihydroceramide. The percentage phosphorylation was
calculated as difference in the arbitrary values between ceramide and dihydroceramide obtained as ratio by relative quantifications. The ratios were
calculated and normalized to b actin. C: JNK regulates HRK expression. HCSF grown in DMEM containing 5%FBS, Mito+, and ciprofloxacin were
treated with 40 mM C6 dihydroceramide (DH) as control or 40 mM C6 ceramide at various times with, or without 10 mM JNK inhibitor SP600125. qPCR
was performed.(1) 40 mM DH, (2) 40 mMD H +SP600125, (3) 40 mM C6-ceramide(6 hrs), (4) 40 mM C6-ceramide (6 hrs)+ SP600125, (5) 40 mM C6-
ceramide (12 hrs), (6) 40 mM C6-ceramide (12 hrs) + SP600125. Data were analyzed using DDCt method and normalized against GAPDH as
housekeeping gene relative to no treatment control (mean6SEM). Statistically significant ((*) p,0.001), ((**) p,0.05) ANOVA with multiple
comparisons (Holm-Sidak method).
doi:10.1371/journal.pone.0018137.g004
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HCSF were transfected with 40 nM siHRK or siNTC (non
target control siRNA) and were subjected to C6 ceramide or C6
dihydroceramide treatment. We found HRK siRNA treatment
significantly reduced steady state mRNA pools of HRK in HCSF
treated with C6 ceramide for 6 or 12 hours compared to siNTC
transfected cells that had been treated with ceramide (Figure 5A).
Cell viability of HCSFs that were transfected with either siHRK or
siNTC and treated with C6 ceramide or C6 dihydroceramide for
3 h, 6 h or 12 h was assessed by calcein AM/Eth-D1 double
staining. We observed siHRK transfection of HCSFs more
effectively rescued cell survival(Figure 5B-j,k,l) compared to
HCSFs transfected with siNTC and treated with C6 ceramide
for 3 h,6 h and 12 h (Figure 5B-g,h,i). Thus transfection with
siHRK significantly knocked-down the ceramide induced cell
death (Figure 5C). The MTT assay was used to verify the pro-
survival role of siHRK. We observed cells transfected with siHRK
were able to reduced MTT to formazan more efficiently than
HCSF transfected with siNTC when treated with C6 ceramide
(Figure 5D).
Discussion
In this study we demonstrated: (1) mitochondrial dysfunction
and cell death in C6 ceramide treated HCSF by the MTT assay
indicating that mitochondrial electron transport had been
disrupted; cell death was confirmed using the calcein AM assay;
(2) the release of cyto c from mitochondrial inter membrane space
(IMS); (3) the loss of DYm loss and (4) enhanced production of
mitochondrial ROS. C6 ceramide induced HRK expression was
mediated by JNK. HRK was translocated to mitochondria from
the cytosol where it interacted with BAD and mitochondrial p32.
Ceramide induced cell death was significantly reduced by HRK
siRNA treatment. Our data provide the first evidence that HCSF
death following ceramide exposure is due to mitochondrial
dysfunction mediated by expression of HRK. Mitochondrial
dysfunction is the critical step involved in C6 ceramide activated
HRK mediated demise of HCSF.
The loss of mitochondrial integrity and function leads to
pathological conditions related to several diseases such as:
diabetes, cardiovascular disorders, neurodegenerative disorders,
and diseases of eye [14,34]. Recently, mitochondrial dysfunction
has been implicated in corneal cell death related to dry eye disease
and keratoconus which contribute to loss of corneal transparency
and decreased vision acuity [13,14]. The hallmarks of mitochon-
drial dysfunction include generation of reactive oxygen species,
ATP depletion, collapse in the inner mitochondrial membrane
potential, inhibition and/or activation of the mitochondrial
electron transport chain, and release of IMS proteins [11]. In
this study, up-regulated expression of HRK (Figure 3A), release of
cyto c in the cytosol (Figure 2D), decreased percent of calcein-AM
positive cells (Figure IA) and decreased reduction of MTT
(Figure 1B) characterize HCSF cell death mediate by ceramide.
Depending on the cell type, death stimulus, and experimental
conditions, multiple molecular mechanisms of mitochondrial
dysfunction may co-exist involving the cyto c release, permeability
transition pore (PTP) complex activity, and the BAX/BAK pore-
forming properties [26,27,35] in causing the MOMP. Regardless
of the mechanisms of cyto c release and DYm loss, once MOMP
occurred, cells appear to reach the ‘‘point of no return’’ and their
fate appears to be sealed [36,37]. Our experimental model
illustrates the basic tenets of a mitochondrial death pathway as
manifested by the defective function of complexes II and III of
respiratory chain in the form of decreased MTT reduced
(Figure 1B); increased localization of cyto c in the cytosol
(Figure 2D); increased production of mitochondrial ROS
(Figure 2A) and loss of DYm (Figure 2B and 2C).
Ceramides regulate BH3 only proteins such as BID [38], BAD
[16] and HRK [18] directly and thus affect complex III of
respiratory chain [38] resulting in release of cyto c into the cytosol
[27]. In our study we found C6 ceramide caused JNK
phosphorylation in regulating HRK production (Figure 4A and
4B). C6 ceramide activated HRK transcription was likely due to
the presence of conserved ATF binding site in HRK promoter
region, where c Jun binds after phosphorylation [39]. Ceramide
treatment not only induced HRK expression at mRNA and
protein levels but also enhanced its translocation to mitochondria
by 12 hours (Figure 3A, 3B) for the release of cyto c. BH3 proteins
undergo posttranslational modification (PTM) in causing inner
mitochondrial membrane remodeling for cyto c release from
cristae [4,12,27,39]. We have not study the absence or presence of
PTM in HRK, nonetheless; we have observed HRK interaction
with mitochondrial p32 (Figure 3C), which is a critical regulator of
mitochondrial membrane potential and cell death [20]. The
interaction of HRK with p32 was necessary for HRK to exert its
pro-death activity [19]. In these studies we have also observed that
HRK siRNA mediated knockdown of HRK resulted in a decrease
in steady state pool of HRK mRNA and reduced the ability of
ceramide to cause mitochondrial dysfunction and cell death
(Figure 5A–D). Thus, it appears that HRK/p32 interactions are
capable of activating a mitochondrial death pathway in HCSF.
P32 may be involved in regulating the mitochondrial concen-
trations of Ca
2+ and permeability transitions of the inner
membrane in association with the PTP complex for releasing the
cyto c [40]. We performed Insilco analyses that revealed the
homology existing among p32, HRK and BAD in the regions of
pre-BH3, BH3 and post-BH3 domains. Homologies also exist in
the N terminal region (aa1-73) of p32 which contains the signal
sequence of p32 that targets mitochondria (Figures S1 and S2)
[19]. In view of the interactions observed among BAD,mitochon-
drial p32 and HRK (Figure 3C) it has been hypothesized that
these complexes are likely to be involved in signaling associated
with the ceramide induced regulation of Ca
2+ and PTP
sensitization in contributing to the mitochondrial dysfunction
and eventually to HCSF death(Figure 2B and 2C). Thus, ceramide
may act as a stimulus of death that causes PTMs in BH3 proteins
by creating active conformations responsible for mitochondrial
dysfunction resulting in the loss of DYm and cyto c release to the
cytosol due to PTP opening of the inner mitochondrial membrane
[4].
We have observed increased production of mitochondrial ROS
(Figure 2A); however, we are not sure about the reason for
increased ROS production following ceramide challenge. The
reduction in DYm coupled with increased generation of ROS may
be due to the induction of NADPH oxidase (NOX) expression
[25,41]. We observed that superoxide can be produced in HCSF
by NADPH oxidases mediated by complexes containing NOXs 1,
4, and 5 [21]. We also have observed the induction of NOX by
ceramide treatment (Rizvi et al unpublished). Therefore we
suggest that ceramide induced NOX may contribute to the
mitochondrial death signaling.
Clearly; our findings provide first evidence that BH3-only
proteins, such as HRK and BAD maybe capable of directly
interacting with mitochondrial protein p32 in HCSF. In this way
they are more close to hierarchy model of BH3-only proteins
activation involving mitochondrial mediated death of HCSF
following the stimulus by ceramide [6]. These protein interactions
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be the key events in the cells response to ceramide and may help in
defining the mechanism of ceramide mediated death of HCSF in
the present paradigm. These observations further suggest the
possibility of endoplasmic reticulum stress and mitochondrial
dysfunction (ERSMD) contributing to the demise of ceramide
treated HCSF [11,12]. As ER stress and JNK signaling pathway
have been linked with both HRK activation and ROS generation
by NADPH oxidases and thereby linked to the process of
mitochondrial permeabilization and cell death [29,42,43]. Due
to the fact that although annexin v staining, activation of caspase 3
on ceramide treatment (data not shown) and TUNEL staining
Figure 5. siHRK knockdown HRK mRNA and ceramide induced cell death. A: HRK knockdown of steady state pool of HRK mRNA. HCSF
grown in DMEM + 5% FBS were transfected with 40 nM siHRK or 40 nM siNTC (as control) for 72 hours. Cells were then treated with 40 mM (DH)
control or 40 mM C6 ceramide for 6 to 12 hours. qPCR was performed (1) siNTC(control)+ 40 mM C6 ceramide (6 h), (2) siHRK+ 40 mM C6 ceramide
(6 h), (3) siHRK + 40 mM C6 ceramide (12 h). Data were analyzed using DDCt method and normalized against GAPDH as housekeeping gene. The fold
change in HRK expression was calculated with respect to siNTC+DH (12 h) treated control. (*) Statistically significant, (#) statistically not significantly
different, (p,0.05) ANOVA with multiple comparisons (Holm-Sidak method) was performed. B: HRK knockdown ceramide induced cell death. HCSF
were grown HCSF grown in DMEM +5% FBS were transfected with 40 nM siHRK or 40 nM siNTC for 72 hours. Cells were then treated with 40 mMD H
and 40 mM C6 ceramide for 3, 6 and 12 hours. Cells washed briefly with HBSS containing Ca
2+ and Mg
2+ and then incubated with calcein AM and
ethidium nuclear stain for 30 min at 37uC. Cell death was determined by fluorescent microscopy(a) siNTC +DH(3 h),(b) siNTC +DH(6 h),(c) siNTC
+DH(12 h),(d) siHRK +DH(3 h), (e) siHRK +DH(6 h), (f) siHRK +DH(12 h),(g) siNTC + ceramide(3 h),(h)siNTC + ceramide(6 h),(i) siNTC + ceramide(12 h) (j)
siHRK + ceramide(3 h),(k) siHRK + ceramide(6 h), (l) siHRK + ceramide(12 h). C: Assessment of siHRK transfected cell survival by MTT assay following
treatment with C6 ceramide. HCSF grown in DMEM +5% FBS were transfected with 40 nM siHRK or 40 nM siNTC (as control) for 72 hours. Cells were
then treated with the following for next 12 hours (1) siNTC+ 40 mM C6 dihydroceramide, (2) siHRK+ 40 mM C6 dihydroceramide or (3) siNTC+ 40 mM
C6 ceramide, (4) siHRK+ 40 mM C6 ceramide or (5) siNTC+ 20 mM C6 ceramide, (6) siHRK+ 20 mM C6 ceramide. Cell survival by siHRK was assessed by
formazan formation. MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium bromide, a tetrazole) was reduced to formazan by living cells.
(*) Statistically significant (p,0.05) ANOVA with multiple comparisons (Holm-Sidak method). D: HRK knockdown prevents ceramide induced cell
death. Panel showing cell survival by siHRK following C6 ceramide treatment, assayed by calcein AM and ethidium nuclear stain. Vertical bars
represent percentage of calcein positive cells relative to total cells counted. (1) siNTC+ 40 mM +C6 dihydroceramide (12 hrs), (2) siHRK+ 40 mMC 6
dihydroceramide (12 hrs), (3) siNTC+ 40 mM C6 ceramide (3 hrs), (4) siHRK+ 40 mM C6 ceramide(3 hrs), (5) siNTC+ 40 mM C6 ceramide (6 hrs), (6)
siHRK+ 40 mM C6 ceramide (6 hrs), (7) siNTC+ 40 mM C6 ceramide(12 hrs), (8) siHRK+ 40 mM C6 ceramide (12 hrs). (*) Statistically significant (p,0.05)
ANOVA with multiple comparisons (Holm-Sidak method) was performed.
doi:10.1371/journal.pone.0018137.g005
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in classic apoptosis it is unclear whether to suggest that the cells
were dying due to necrosis, apoptosis, or the combination of both
(Figures S3 and S4). Additional studies will be required to
investigate the specific nature of ceramide induced cell death, the
upstream events causal for JNK phosphorylation and the
downstream events followed by HRK translocation to mitochon-
dria in order to delineate the precise signaling mechanism
operative in the mitochondrial dysfunction for the demise of
HCSF. Better comprehension of such mechanism(s) may lead to
the identification of new targets for drugs used to regulate corneal
wound healing and maintenance of corneal clarity.
Supporting Information
Figure S1 Figure showing amino acid sequence align-
ment between HRK and p32 in the region of Pre BH3,
BH3 and post BH3 domains. Alignment can also be seen with
N terminal region of p32, amino acids 1–73 (Blue solid) which
contains the signal sequence of p32 that target mitochondria.
Sequence alignment was done using T-Coffee (see File S1).
(TIF)
Figure S2 Figure showing amino acid sequence align-
ment between BAD and p32 in the region of Pre BH3,
BH3 and post BH3 domains. Alignment can also be seen with
N terminal region of p32, amino acids 1-73 (Blue solid) which
contains the signal sequence of p32 that target mitochondria.
Sequence alignment was done using T-Coffee (see File S1).
(TIF)
Figure S3 TUNEL positive cells present in cultures
following C6-ceramide treatment. Cells were grown to
confluence and treated overnight with 40 mM C6 cer-
amide (left panel), or 5 nM staurosporine (right panel).
Cells were harvested and stained using TUNEL kits. The cells
were analyzed by flowcytometry. Alexa Flour 488-A stained
represent BrdU positive cells and PE-A stained represent
propidium iodide positive cells (see File S2).
(TIF)
Figure S4 Annexin V-affinity, resulting from phospha-
tidylserine (PS) exposure at the outer leaflet of the
plasma membrane, apoptotic cells can be distinguished
from annexin V-negative living cells, by using fluores-
cent microscopy procedure. When combined with propidium
iodide (PI) the double labeling procedure allows a further
distinction of necrotic (pink arrow head, annexin V-/PI+), early
apoptotic (green arrow head, annexin V+/PI-) or late apoptotic/
necrotic (yellow arrow head, annexin V+/PI+) cells. The cells were
used for fluorescent microscopy; the images were captured and
measured for green and red fluorescence. Cells were treated with
dihydroceramide (a) or 40 mM C6 ceramide (b) (see File S2).
(TIF)
File S1 Reference for Figures S1 and S2.
(DOC)
File S2 Material and Methods for Figures S3 and S4.
(DOC)
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